Abiopharma

🔍 Weinhoff Gregory M (Executive)

Company: Centessa Pharmaceuticals plc (CNTA)

Report Date: 2026-03-26

Detailed Transactions and Holdings:

• Acquired 23,998 shares of Ordinary Shares at $3.85 per share (Direct)
  Date: 2026-03-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 89,923.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 23,998 shares of Ordinary Shares at $30.0 per share (Direct)
  Date: 2026-03-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,925.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 23,998 shares of Share Option (right to buy) at $3.85 per share (Derivative)
  Date: 2026-03-26 | Code: M | Expires: 2033-02-01 | equity_swap_involved: 0 | shares_owned_after: 31,002.00 | transaction_form_type: 4 | Footnotes: F3, F1

Footnotes:

• F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.
• F3: 1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.